Human medicines European public assessment report (EPAR): Synflorix, pneumococcal polysaccharide conjugate vaccine (adsorbed), Pneumococcal Infections,Immunization, Date of authorisation: 29/03/2009, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Pneumococcal Infections,Immunization, Date of authorisation: 09/12/2009, Revision: 33, Status: Authorised

Case Medical Research ◽

10.31525/cmr-39966c ◽

2019 ◽

Author(s):

Keyword(s):

Conjugate Vaccine ◽

Pneumococcal Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Pneumococcal Infections,Immunization, Date of authorisation: 09/12/2009, Revision: 34, Status: Authorised

Case Medical Research ◽

10.31525/cmr-913582 ◽

2019 ◽

Author(s):

Keyword(s):

Conjugate Vaccine ◽

Pneumococcal Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Synflorix, pneumococcal polysaccharide conjugate vaccine (adsorbed), Pneumococcal Infections,Immunization, Date of authorisation: 29/03/2009, Revision: 31, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871c8 ◽

2018 ◽

Author(s):

Keyword(s):

Conjugate Vaccine ◽

Pneumococcal Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Menveo, meningococcal group A, C, W-135 and Y conjugate vaccine, Immunization,Meningitis, Meningococcal, Date of authorisation: 15/03/2010, Date of refusal: 17/12/2009, Revision: 28, Status: Authorised

Case Medical Research ◽

10.31525/cmr-c3f2ac ◽

2019 ◽

Author(s):

Keyword(s):

Conjugate Vaccine ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group A

Download Full-text

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal group A, C, W 135 and Y conjugate vaccine, Meningitis, Meningococcal, Date of authorisation: 20/04/2012, Revision: 27, Status: Authorised

Case Medical Research ◽

10.31525/cmr-913577 ◽

2019 ◽

Author(s):

Keyword(s):

Conjugate Vaccine ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group A

Download Full-text

Human medicines European public assessment report (EPAR): Vaxelis, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed), Meningitis, Haemophilus,Poliomyelitis,Tetanus,Diphtheria,Whooping Cough,Hepatitis B, Date of authorisation: 15/02/2016, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-bb17b9 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Conjugate Vaccine ◽

Whooping Cough ◽

Type B ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal group A, C, W 135 and Y conjugate vaccine, Meningitis, Meningococcal, Date of authorisation: 20/04/2012, Revision: 26, Status: Authorised

Case Medical Research ◽

10.31525/cmr-908f20 ◽

2019 ◽

Author(s):

Keyword(s):

Conjugate Vaccine ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group A

Download Full-text

Human medicines European public assessment report (EPAR): Menveo, meningococcal group A, C, W-135 and Y conjugate vaccine, Immunization,Meningitis, Meningococcal, Date of authorisation: 15/03/2010, Date of refusal: 17/12/2009, Revision: 26, Status: Authorised

Case Medical Research ◽

10.31525/cmr-c4dbb1 ◽

2019 ◽

Author(s):

Keyword(s):

Conjugate Vaccine ◽

Assessment Report ◽

European Public ◽

Meningococcal Group ◽

European Public Assessment Report ◽

Group A

Download Full-text

Human medicines European public assessment report (EPAR): Vaxelis, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed), Meningitis, Haemophilus,Poliomyelitis,Tetanus,Diphtheria,Whooping Cough,Hepatitis B, Date of authorisation: 15/02/2016, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-babd67 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Conjugate Vaccine ◽

Whooping Cough ◽

Type B ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Fabrazyme, agalsidase beta, Fabry Disease, Date of authorisation: 03/08/2001, Revision: 26, Status: Authorised

Case Medical Research ◽

10.31525/cmr-19715f1 ◽

2019 ◽

Author(s):

Keyword(s):

Fabry Disease ◽

Agalsidase Beta ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text